• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OLYMPUS MEDICAL SYSTEMS CORP. EVIS LUCERA DUODENOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OLYMPUS MEDICAL SYSTEMS CORP. EVIS LUCERA DUODENOVIDEOSCOPE Back to Search Results
Model Number JF-260V
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Perforation (2001); Pancreatitis (4481); Unspecified Hepatic or Biliary Problem (4493)
Event Date 12/02/2021
Event Type  Injury  
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.Tjf-260v may have been used but the authors did not specify.The literature article is attached for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Event Description
Olympus reviewed a literature titled "endoscopic retrograde cholangiopancreatography-related complications for bile duct stones in asymptomatic and symptomatic patients".This retrospective multicenter study was aimed to compare the risks of endoscopic retrograde cholangiopancreatography (ercp) for the removal of common bile duct (cbd) stones, between asymptomatic and symptomatic patients.The study included 1491 patients with choledocholithiasis at three institutions in (b)(6) and was evaluated for the incidence rates of overall ercp-related complications and the severity as the primary outcome.The secondary outcomes were the incidence rates and severities of each ercp-related complication such as; post-ercp pancreatitis (pep), perforation.Cholangitis, and bleeding.The reported rates for complications were 7.5% in the asymptomatic group vs 6.1% in the symptomatic group (p < 0.001).The study concluded that, however, both the groups were at equal risks of post-ercp cholangitis, bleeding, and perforation; but, ercp for asymptomatic patients with cbd stones had a higher risk of overall complications than that for symptomatic patients.The authors reported using two different olympus evis lucera duodenoscopes, jf-260 or tjf-260v and did not specify which scope was used on the patients with adverse events.Jf-260v was selected as a representative product.[asymptomatic group; n = 172]: overall ercp-related complications - (31).Mild post-ercp pancreatitis (pep) - (10).Moderate pep - (8).Severe pep - (3).Mild-cholangitis - (2).Moderate-cholangitis - (2).Mild-bleeding - (1).Moderate-bleeding - (1).Severe-bleeding - (1).Mild -perforation - (1).Moderate -perforation - (1).Severe -perforation - (1).[symptomatic group; n = 1319]: overall ercp-related complications - (81).Mild pep - (27).Moderate pep - (7).Severe pep - (1).Mild-cholangitis - (13).Moderate-cholangitis - (6).Mild-bleeding - (15).Moderate-bleeding - (4).Severe-bleeding - (2).Mild -perforation - (2).Moderate -perforation - (4).
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS LUCERA DUODENOVIDEOSCOPE
Type of Device
DUODENOVIDEOSCOPE
Manufacturer (Section D)
OLYMPUS MEDICAL SYSTEMS CORP.
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8 507
JA  192-8507
Manufacturer Contact
kazutaka matsumoto
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8-507
JA   192-8507
426425177
MDR Report Key13733872
MDR Text Key291597298
Report Number8010047-2022-04285
Device Sequence Number1
Product Code FDT
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/01/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberJF-260V
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 02/13/2022
Initial Date FDA Received03/11/2022
Supplement Dates Manufacturer Received06/03/2022
Supplement Dates FDA Received07/01/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-